Parametric Portfolio Associates’s MacroGenics MGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$364K Buy
41,280
+2,728
+7% +$30.1K ﹤0.01% 3218
2021
Q4
$619K Sell
38,552
-43,493
-53% -$819K ﹤0.01% 2981
2021
Q3
$1.72M Sell
82,045
-2,557
-3% -$61.6K ﹤0.01% 2521
2021
Q2
$2.27M Buy
84,602
+688
+0.8% +$20.1K ﹤0.01% 2362
2021
Q1
$2.67M Buy
83,914
+43,981
+110% +$1.07M ﹤0.01% 2591
2020
Q4
$913K Sell
39,933
-2,864
-7% -$65.9K ﹤0.01% 3094
2020
Q3
$1.08M Buy
42,797
+1,203
+3% +$32.8K ﹤0.01% 2882
2020
Q2
$1.16M Buy
41,594
+518
+1% +$9K ﹤0.01% 2832
2020
Q1
$239K Sell
41,076
-13,343
-25% -$121K ﹤0.01% 3474
2019
Q4
$592K Sell
54,419
-28,207
-34% -$279K ﹤0.01% 3307
2019
Q3
$1.05M Buy
82,626
+44,615
+117% +$643K ﹤0.01% 2998
2019
Q2
$645K Sell
38,011
-19,720
-34% -$339K ﹤0.01% 3263
2019
Q1
$1.04M Buy
57,731
+18,137
+46% +$314K ﹤0.01% 3015
2018
Q4
$503K Buy
39,594
+19,154
+94% +$321K ﹤0.01% 3311
2018
Q3
$438K Sell
20,440
-5,238
-20% -$112K ﹤0.01% 3467
2018
Q2
$530K Buy
25,678
+3,274
+15% +$73.7K ﹤0.01% 3319
2018
Q1
$564K Buy
22,404
+3,489
+18% +$84.7K ﹤0.01% 3281
2017
Q4
$359K Buy
18,915
+7,364
+64% +$137K ﹤0.01% 3491
2017
Q3
$213K Sell
11,551
-27
-0.2% -$468 ﹤0.01% 3830
2017
Q2
$203K Buy
+11,578
New +$221K ﹤0.01% 3802

Other funds holding MGNX

Parametric Portfolio Associates's MGNX Position: Q1 2022 in Review

Parametric Portfolio Associates increased its MacroGenics (MGNX) stake by 7.1% in Q1 2022, buying an estimated $30.1K and bringing the position to 41,280 shares worth $364K. The position accounts for ﹤0.01% of the portfolio, ranked #3218.

Parametric Portfolio Associates first reported a position in MGNX in Q2 2017 and has held it in 20 quarters since. The position peaked at $2.67M in Q1 2021. 144 funds tracked by Wall St. Rank hold MGNX as of Q1 2022.

  • Parametric Portfolio Associates held 41,280 shares of MacroGenics worth $364K as of Q1 2022.
  • Parametric Portfolio Associates bought 2,728 MacroGenics shares in Q1 2022, an estimated $30.1K.
  • MacroGenics made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3218 holding.
  • Parametric Portfolio Associates first reported a position in MacroGenics in Q2 2017 and has held it in 20 quarters since.
  • Parametric Portfolio Associates's MacroGenics position peaked at $2.67M in Q1 2021.
  • 144 funds tracked by Wall St. Rank held MacroGenics as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.